Tomahawk, WI 06/25/2014 (Basicsmedia) –  Traders take the position according to the swings and technical indicators whereas the investors take the positions considering the fundamentals of any company. What the both groups should do in case of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)?

Entry into the oversold zone

Coming to the technical indicators, traders always refer to the most used technical analysis indicator known as the RSI or the Relative Strength Index.  The stocks are measured on a scale of zero to 100. As per the RSI, if a stock goes below 30, it comes in the oversold territory and is set for a bounce back.

So relating the same concept with Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), let us check out what the RSI says? Arena Pharmaceuticals is now into the oversold zone. It is trading at an RSI reading of 29.2. On the other hand, the index S&P 500 ETF (SPY) reading is at 65.1 which is set to enter the overbought zone.

The warning sign

Does it mean that traders should opt for a contra trade? Well, seeing the RSI position of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), traders would like to jump for buying the stocks as it seems it is done with the selling. But it can prove to be a detrimental step.  It might have entered into the oversold territory; still it is better to stay away from it.

The wise people have said that never catch a falling knife in the stock market. Let the first signs of a rebound come in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA). It will then be a clear indication to enter the stock. As of now, the stock is trading around $5.85. It has hit a 52 week high of $8.48 and has a 52 week low of $4.05 per share. The company may come up with its earnings, not before July 2014. So, it is better to take some light positions in the stock till the time it gives a strong reversal of “buy.”

DISCLAIMER: This content is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.